Literature DB >> 24100548

Distribution and neurochemical characterization of neurons in the rat ventrolateral medulla activated by glucoprivation.

Lindsay M Parker1, Natasha N Kumar, Tina Lonergan, Simon McMullan, Ann K Goodchild.   

Abstract

Hypoglycemia elicits physiological and behavioral responses which are mediated in part by neurons within the ventrolateral medulla (VLM). The present study describes the neurochemistry of neurons activated by glucoprivation (2-deoxy-D-glucose, 2DG), specifically those within regions containing the A1, caudal C1 (cC1) and rostral C1 (rC1) cell groups. 2DG induced c-Fos immunoreactivity throughout the VLM. Activated neurons expressing prepro-cocaine and amphetamine-regulated transcript (PPCART), neuropeptide Y (NPY), glutamic acid decarboxylase (GAD67) or prepro-enkephalin (PPE) mRNA and/or immunoreactivity (-ir) for tyrosine hydroxylase (TH) were identified. TH(+) neurons were recruited in a dose-dependent manner. At high doses of 2DG [400 mg/kg, (n = 6)], 76 ± 1.2 % of activated neurons were TH(+) representing 52 ± 1.3 % of the total TH population. Virtually all activated neurons in the A1 and cC1 regions but only 60 % in the rC1 region were TH(+). Within the A1 region, TH(+), TH(+)NPY(+) and TH(+)NPY(+)PPE(+) subpopulations were activated and likely regulate vasopressin, oxytocin, and corticotrophin releasing hormone (CRH) from the hypothalamus. Within the cC1 region, non-TH neurons, TH(+)NPY(+), TH(+)NPY(+)PPCART(+), and TH(+)NPY(+)PPE(+) subpopulations were activated, likely regulating autonomic hypothalamic neurons or CRH and thyrotropin releasing hormone secretion. Within the rC1 region, non-TH neurons (40 % of those activated) were predominantly PPE(+) and were recruited by higher 2DG doses. Of the TH(+) activated neurons in the rC1 region, many expressed PPCART and half expressed NPY. The activated spinally projecting population was almost entirely TH(+)PPCART(+) and is likely to regulate adrenaline and glucagon release. These data indicate that glucoprivation activates at least nine phenotypically distinct populations of neurons in the VLM.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24100548     DOI: 10.1007/s00429-013-0642-3

Source DB:  PubMed          Journal:  Brain Struct Funct        ISSN: 1863-2653            Impact factor:   3.270


  6 in total

1.  Npy deletion in an alcohol non-preferring rat model elicits differential effects on alcohol consumption and body weight.

Authors:  Bin Qiu; Richard L Bell; Yong Cao; Lingling Zhang; Robert B Stewart; Tamara Graves; Lawrence Lumeng; Weidong Yong; Tiebing Liang
Journal:  J Genet Genomics       Date:  2016-04-29       Impact factor: 4.275

2.  The Effects of Insulin-Induced Hypoglycaemia on Tyrosine Hydroxylase Phosphorylation in Rat Brain and Adrenal Gland.

Authors:  Manjula Senthilkumaran; Michaela E Johnson; Larisa Bobrovskaya
Journal:  Neurochem Res       Date:  2016-03-02       Impact factor: 3.996

3.  Selective Pharmacogenetic Activation of Catecholamine Subgroups in the Ventrolateral Medulla Elicits Key Glucoregulatory Responses.

Authors:  Ai-Jun Li; Qing Wang; Sue Ritter
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

4.  Hypoglycemia-activated Hypothalamic Microglia Impairs Glucose Counterregulatory Responses.

Authors:  Zsuzsanna Winkler; Dániel Kuti; Ágnes Polyák; Balázs Juhász; Krisztina Gulyás; Nikolett Lénárt; Ádám Dénes; Szilamér Ferenczi; Krisztina J Kovács
Journal:  Sci Rep       Date:  2019-04-17       Impact factor: 4.379

5.  Repetitive hypoglycemia reduces activation of glucose-responsive neurons in C1 and C3 medullary brain regions to subsequent hypoglycemia.

Authors:  Zohra M Kakall; Mary M Kavurma; E Myfanwy Cohen; Peter R Howe; Polina E Nedoboy; Paul M Pilowsky
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-04-23       Impact factor: 4.310

Review 6.  A Student's Guide to Neural Circuit Tracing.

Authors:  Christine Saleeba; Bowen Dempsey; Sheng Le; Ann Goodchild; Simon McMullan
Journal:  Front Neurosci       Date:  2019-08-27       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.